S&P 500
773.38
-0.02%
DOW
518.00
-0.34%
NASDAQ
747.46
+0.81%
Russell
287.21
+0.57%
VIX
16.63
-4.32%
FTSE
47.67
-0.04%
Nikkei
98.78
+0.84%
BTC
86,216.09
-0.85%
ETH
2,749.64
-1.16%
Gold
400.07
+0.42%
Oil
144.08
-2.75%
Silver
60.73
+1.84%
S&P 500
773.38
-0.02%
DOW
518.00
-0.34%
NASDAQ
747.46
+0.81%
Russell
287.21
+0.57%
VIX
16.63
-4.32%
FTSE
47.67
-0.04%
Nikkei
98.78
+0.84%
BTC
86,216.09
-0.85%
ETH
2,749.64
-1.16%
Gold
400.07
+0.42%
Oil
144.08
-2.75%
Silver
60.73
+1.84%
Stock
Ti
News
Markets
Stocks
Screener
Calendar
Watchlist
Loading...
Home
/
Stocks
/
CATX
/
News
CATX
AMEX · Biotechnology
Perspective Therapeutics Inc
Small-Cap Stocks
Penny Stocks
Biotech Stocks
Healthcare Stocks
$2.88
+0.00 (+0.00%)
☆ Watch
As of Sep 20, 10:25 PM ET ·
Overview
Earnings
Forecast
Financials
News
Peers
CATX News
1 articles
Angels' $4B Deal Puts Braves' Valuation in Perspective
A reported $4 billion price for the Angels aligns closely with Atlanta Braves Holdings' enterprise value, but the comparison is less bullish once debt and non-baseball assets are considered.
Analysis
Sep 5
↑